Catherine B Stack

Title: The Innovations of Catherine B Stack

Introduction

Catherine B Stack is a notable inventor based in Old Saybrook, Connecticut. She has made significant contributions to the field of pharmacogenetics, particularly in understanding how genetic variations can influence drug responses. Her work has implications for personalized medicine and the development of more effective treatments.

Latest Patents

Catherine holds a patent titled "Association of β2-adrenergic receptor haplotypes with drug response." This patent discloses genotypes and haplotypes for thirteen polymorphic sites in the β-adrenergic receptor (β AR) gene. It also includes compositions and methods for predicting genetic predisposition to diseases associated with these polymorphic sites, as well as for predicting responses to β-agonists.

Career Highlights

Catherine is currently associated with Genaissance Pharmaceuticals, Inc., where she continues to advance her research in pharmacogenetics. Her work is pivotal in bridging the gap between genetics and therapeutic efficacy, enhancing the understanding of how individual genetic makeup can affect drug metabolism and response.

Collaborations

Catherine has collaborated with esteemed colleagues such as Connie M Drysdale and Richard S Judson. These collaborations have enriched her research and contributed to the broader scientific community's understanding of genetic influences on drug response.

Conclusion

Catherine B Stack's innovative work in pharmacogenetics exemplifies the importance of personalized medicine. Her contributions through her patent and collaborations continue to pave the way for advancements in understanding drug responses based on genetic variations.